Sale of Product Line, Patent & Patent Pending Portfolio
Executive Summary
Innovative patent and product portfolio for sale from the inventor of the widely recognized standard in implantable port devices. Portfolio includes: a complete line of FDA approved vascular access implantable ports, an FDA approved line of Huber point needle infusion sets, a safety Huber point patent and two (2) new patent pending implantable port designs proven to diminish, if not eliminate the accumulation of reservoir sludge* suspected to cause bacterial infection in some patients.
The patent pending technologies include the development of a new chamber design for a line of implantable ports and a new reservoir and septum design for a line of implanted peripherally inserted central catheter (PICC) devices. The specific patent applications cover an innovative rounded port chamber as opposed to the toroid or cylindrical chamber that is the current standard in ports. The new design solves the problem in ports created by the flat septum on top of a cylindrical chamber/reservoir where bacteria can form. This is accomplished with a unique radius geometry that allows clear flow and total cleaning of the chamber with each needle access. The new PICC device technology is a tubular self-sealing septum that will allow wider use due to a smaller device that minimizes erosion and extrusion problems with parallel access to the skin.
This portfolio for sale will bring immediate access to a growing implanted drug delivery device market with a full line of very competitive products and two new innovations with unlimited market potential. This is a large, growing rather mature marketplace with little differentiation in the products being offered. The product line offered here provides instant access to that market with new innovative patent pending products in the development pipeline for the potential to gain market share quickly.
The owner, who has over 30 years of experience in implanted port devices, can provide ongoing technical and manufacturing support for a smooth transition. The device portfolio is expected to be of interest to both strategic and industry acquirers looking to enter the vascular access market or upgrade their current portfolio and technologies.
* Sludge - drug precipitates and residual blood products.
Portfolio Assets:
| Group | Title/Description | Dimensions | Patents-Approvals |
|---|---|---|---|
|
Standard Single Lumen Port Systems |
Small Titanium or Polysulfone ports with silicone or polyurethane catheter |
Height: 8mm |
FDA Approved |
|
Medium Titanium or Polysulfone Ports with Silicone or Polyurethane Catheter |
Height: 10mm |
FDA Approved |
|
|
Large Titanium or Polysulfone Ports with Silicone or Polyurethane Catheter |
Height: 13mm |
FDA Approved |
|
|
Power Ports |
Implantable Venous Power Port with Silicone or polyurethane catheter |
Height: 29mm |
Passed New Product Testing 510(k) submitted Approval 8/11 |
|
Spherical Chamber Ports |
Large & Medium Titanium Spherical Chamber Port with Silicone or Polyurethane Catheter |
Height: 9.8mm |
Patent Pending |
|
Radius Septum Peripherally Inserted Central Catheter |
Medium Unique Septum (PICC) with Silicone or Polyurethane Catheter |
Height: 14.6mm |
Patent Pending |
|
Small Unique Septum (PICC) with Silicone or Polyurethane Catheter |
Height: 10.5mm |
Patent Pending |
|
|
Safety Huber Point Needles |
Unique Low Profile Design currently in Concept only |
Requires Engineering and Manufacturing |
Patented |
|
Complete Line Huber Point Needles |
Designed for standard and power injection ports |
Needle Gauge: 19-22 |
FDA Approved |
This information is provided for discussion purposes only. No representation is made as to the accuracy of the information provided or any other information supplied. Broker encourages the Prospect to thoroughly review and independently verify to his own satisfaction, that the information provided is substantially representative of the business activity.
Deal Structure
Asset Sale
Other Information
None
Ownership: Privately Held Medical Device Company.
Reason For Sale: Lack of Sales and Distribution Network.
Transition: The seller will provide manufacturing assistance for a smooth transition.